₹ 16.231
NAV (Oct 17)
Investment Duration5 years
0
Total Investment0
Wealth Gained0
Total Corpus Created (₹)
With CAGR of 11.25 % in 5 years₹ 16.231
NAV (Oct 17)
Last 1Y | 64.3% |
Last 3Y | NA |
Last 5Y | NA |
Last 10Y | NA |
Since Inception | 61.8% |
6 Month CAGR | 33.3% |
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Expense Ratio | 2.24% |
Launched 1Y ago | 2023-10-04 |
AUM in Crores | 1302.7 |
ISIN | INF179KC1HL7 |
Lock-in | No Lock-in |
Benchmark | BSE Healthcare Index |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Standard Deviation (3yr) | - |
Standard Deviation | - |
Beta | - |
Sharpe Ratio | - |
YTM | - |
of
for
with step up of
Asset | Returns | Total Corpus | Gains | CAGR |
---|---|---|---|---|
HDFC Pharma And Healthcare Fund (G) | 47,39,952 | 40,07,340 | 64.3% | |
EPF | 9,00,761 | 1,68,149 | 8.50% | |
Property | 8,67,662 | 1,35,050 | 7.00% | |
PPF | 8,69,819 | 1,37,207 | 7.10% | |
Bank FD | 8,46,471 | 1,13,859 | 6.00% | |
Gold | 8,46,471 | 1,13,859 | 6.00% | |
Savings Bank | 8,25,950 | 93,338 | 5.00% |
Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.
Sun Pharmaceutical Industries Ltd.
12.46%Divi's Laboratories Ltd.
7.56%Dr. Reddy's Laboratories Ltd.
5.89%Cipla Ltd.
5.87%Lupin Ltd.
5.12%Healthcare
99.45%Fund Name | Fund Size | |
---|---|---|
₹ 26,417 cr | ||
₹ 24,508 cr | ||
₹ 66,206 cr | ||
₹ 51,197 cr | ||
₹ 17,770 cr |
HDFC Mutual Fund
Fund Name | Scripbox Opinion | Till Date CAGR | |
---|---|---|---|
15.4% | 6.7% | ||
5.7% | 5.9% | ||
20.5% | 13.3% | ||
6.5% | 7.8% | ||
6% | 8.1% |
HDFC Pharma And Healthcare Fund Regular Plan Growth is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 61.77% over 1 years. The fund has grown over a period of 1 years. The fund is managed by HDFC Mutual Fund. The fund managers are Dhruv Muchhal, Nikhil Mathur.
Nav of HDFC Pharma And Healthcare Fund as of 10/17/2024 is ₹16.23 with the total AUM as of 10/18/2024 is ₹1302.67. With Scripbox you can compare and check the latest nav for all mutual funds in India. HDFC Pharma And Healthcare Fund was launched on 2023-10-04.
The minimum SIP amount for HDFC Pharma And Healthcare Fund Regular Plan Growth is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.
HDFC Pharma And Healthcare Fund Regular Growth is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to BSE Healthcare Index.
Scripbox provides a compare mutual funds research tool to view a detailed comparison with HDFC Pharma And Healthcare Fund.
What is HDFC Pharma And Healthcare Fund?
How to invest in HDFC Pharma And Healthcare Fund?
You can invest in HDFC Pharma And Healthcare Fund Regular Plan through AMC, intermediaries, brokers or platforms like Scripbox. To learn step by step process visit how to invest in mutual funds?
What is the minimum sip amount of HDFC Pharma And Healthcare Fund?
The minimum sip amount for HDFC Pharma And Healthcare Fund Regular Plan is ₹1000. You can invest in multiples of ₹5000.
What is the expense ratio of the HDFC Pharma And Healthcare Fund Regular Plan Growth?
The expense ratio of the HDFC Pharma And Healthcare Fund Regular Growth is 2.24% for regular plan.
What is the NAV of HDFC Pharma And Healthcare Fund?
Today's HDFC Pharma And Healthcare Fund Regular Growth NAV is ₹16.23.